Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$315K Hold
2,171
– – 0.2% 102
2026
Q2
$279K Hold
2,171
– – 0.18% 101
2026
Q1
$261K Hold
2,171
– – 0.17% 92
2025
Q4
$229K Buy
+2,171
New +$204K 0.16% 81
2024
Q4
$208K Buy
+2,087
New +$215K 0.15% 106

Other funds holding MRK

Blue Capital's MRK Position: Q3 2026 in Review

Blue Capital held its Merck (MRK) position steady in Q3 2026 at 2,171 shares worth $315K. The position accounts for 0.2% of the portfolio, ranked #102.

Blue Capital first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Blue Capital held 2,171 shares of Merck worth $315K as of Q3 2026.
  • Blue Capital left its Merck share count unchanged in Q3 2026.
  • Merck made up 0.2% of Blue Capital's portfolio in Q3 2026, its #102 holding.
  • Blue Capital first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.